Roche Sales Promise Solid Growth, Pumped by Cancer Drugs
Swiss drug-maker Roche Holding AG on Thursday revealed a 2 percent rise in its third-quarter sales, pumped by strong demand for its cancer drugs and up-and-coming new products. The
Swiss drug-maker Roche Holding AG on Thursday revealed a 2 percent rise in its third-quarter sales, pumped by strong demand for its cancer drugs and up-and-coming new products. The